Germany
Japan
United Kingdom
China
Anti-ERBB1 / EGFR / HER1 Reference Antibody (modotuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadAnti-ERBB1 / EGFR / HER1 Reference Antibody (cetuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (matuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Serclutamab talirine)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (7A7)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Duke D2C7)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- ERBB1 / EGFR / HER1
Applications
- FACS